CN Patent

CN1332711C — 施用glp－1分子的方法

Assigned to Amy Ball Technology Co ltd · Expires 2007-08-22 · 19y expired

What this patent protects

本发明包括证明口服吸收可行的制剂，其中包含GLP-1化合物和特定递送剂的制剂。

USPTO Abstract

本发明包括证明口服吸收可行的制剂，其中包含GLP-1化合物和特定递送剂的制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN1332711C
Jurisdiction
CN
Classification
—
Expires
2007-08-22
Drug substance claim
No
Drug product claim
No
Assignee
Amy Ball Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.